There is a paucity of studies showing sparing calcification in EIA despite gross calcifications in different adjacent vascular segments, abdominal aorta, CIA, and CFA. We examined the distribution map of calcified plaque, focusing on four different arterial segments to determine the lowest calcification score among them and we found out that EIA shows a significantly lower degree of atherosclerotic calcification compared to abdominal aorta, CIA and CFA. The importance of this finding may influence decisions for the usefulness of harvested EIA as an allograft in place of synthetic grafts or xenografts, which are currently used for some cases who are in need of a vascular graft.
Conduit calcification and stenosis is one of the complications in the placement of right ventricle to pulmonary artery conduit (
7). Previously, the pulmonary homograft (PH) was selected mostly for the right ventricle to pulmonary artery (RV-PA) conduit (
8). However, calcification and stenosis with deterioration of valve function have been shown in different studies (
8-
10). Amongst various conduit materials, the expanded polytetrafluoroethylene (ePTFE) has yielded minimal rates of complications including conduit stenosis, conduit regurgitation and conduit reoperation (
8,
11). Despite its benefits, the availability of ePTFE could be limited at small institutions. Based on our findings, EIA could be used as a graft target due to its less calcific plaque burden compared to the adjacent arterial bed. There is scant evidence of using EIA as a conduit placement option. It may be worthy to plan a study for harvesting EIA as cadaver arterial allograft for placement of the right ventricle to pulmonary artery conduit with regards to relative atherosclerotic sparing of the EIA.
Additionally, future studies could be performed in order to demonstrate EIA as a less vasculopathic arterial graft target in different regions. This can be done by end-to-end anastomosis to the patent part and replacing the occluded section by EIA.
It is well established that vascular calcification is the main cause of multiple complications in renal transplant surgeries, including the process of anastomosis, difficulty in vessel clamping, impaired graft function, and the occurrence of arterial steal syndrome or limb ischemia (
12). Most practices require an entity of vascular imaging (usually an ultrasound) before deciding the proper site for anastomosis of the new implant, in part to assess the size and health of patent arteries. Calcification can occur in either the intimal or medial layer of the arteries (
13). Intimal calcifications can be accelerated by advanced age, diabetes, and the presence of atherosclerosis; however, medial calcification can be found in people of younger age and in those who are on dialysis therapy (
3). Aitken et al. showed high intraoperative complication rates and delayed graft function in patients with moderate to severe vascular calcifications (
12).
The presence of vascular calcification has an impact on fusion and anastomosis events, which exacerbates the condition. Agatston score as an additional prognostic factor can describe arterial calcification. Therefore, careful evaluation and scoring of vascular calcification based on Agatston score preceding surgery may facilitate surgical intervention and improve efficacy and outcomes.
At our institution, most of the renal transplantations are performed by end-to-end anastomosis to the internal iliac artery (IIA). Previously, some studies favored EIA end-to-side anastomosis over other arteries in renal transplantation (
14). This finding could be attributed to larger caliber, existence of accessory renal arteries, and lower risk of compromising distal vascular supply to the pelvis (
14,
15). However, Matheus et al. called this finding into question by showing no differences in clinical or surgical complications for arterial anastomosis between end-to-side anastomosis to the EIA and end-to-end anastomosis to the IIA (
16).
This study compares calcification plaque in different segments of pelvic arteries. Our findings suggest that EIA can possibly be a less vasculopathic target for arterial grafts.
Our study was limited by its retrospective design and its small sample size, which reduced its precision. Therefore, future studies with larger sample sizes, more detailed evaluation of patient’s history and CT angiography as a better choice to define plaque burden will be necessary for better understanding of this phenomenon and its etiology.
In conclusion, EIA has a significantly lower degree of atherosclerotic calcification compared to the adjacent vasculature. This can prove a useful alternative in selecting a less diseased target for arterial graft and pelvic solid organ arterial anastomoses.